Expression of B-Cell Markers in Classical Hodgkin Lymphoma: A Tissue Microarray Analysis of 330 Cases

This publication has 27 references indexed in Scilit:

• The expression of the B-cell marker mb-1 (CD79a) in Hodgkin's disease
  Histopathology, 2007
• Loss of the B-lineage–specific gene expression program in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma
  Blood, 2003
• High‐throughput tissue microarray analysis of G1‐cyclin alterations in classical Hodgkin's lymphoma indicates overexpression of cyclin E1
  The Journal of Pathology, 2003
• Treatment of relapsed CD20+ Hodgkin lymphoma with the monoclonal antibody rituximab is effective and well tolerated: results of a phase 2 trial of the German Hodgkin Lymphoma Study Group
  Blood, 2003
• Hodgkin and Reed-Sternberg cells harbor alterations in the major tumor suppressor pathways and cell-cycle checkpoints: analyses using tissue microarrays
  Blood, 2002
• Tissue microarray (TMA) technology: miniaturized pathology archives for high-throughputin situ studies
  The Journal of Pathology, 2001
• Varied B‐cell immunophenotypes of Hodgkin/Reed–Sternberg cells in classic Hodgkin's disease
  Histopathology, 2000
• Tissue microarrays for high-throughput molecular profiling of tumor specimens
  Nature Medicine, 1998
• The B29 and mb‐1 polypeptides are differentially expressed during human B cell differentiation
  European Journal of Immunology, 1992
• Monoclonal Antibodies in the Diagnosis of Hodgkinʼs Disease
  The American Journal of Surgical Pathology, 1988